Yale Cardiovascular Medicine is pleased to announce that five fellows have been promoted to faculty. Specialties include coronary microcirculation, cardiotoxicity associated with cancer therapies, and heart failure.
Antonio A. Giaimo, MD
Teach for American alumnus, Antonio Giaimo, MD, received his medical degree from New York Medical College in 2014. He served as chief resident at Yale New Haven Hospital before completing his fellowship in cardiovascular medicine.
Giaimo was selected as a 2018 Hypertension Early Career Oral Award Finalist at the American Heart Association’s Council of Hypertension Conference in Chicago, IL for a pilot study, “Hypertensive Urgency: An Emergency Department Pipeline to Primary Care Pilot Study.” He also conducted a multicenter, longitudinal study on P2Y12 inhibitors.
Attila Feher, MD, PhD
Attila Feher, MD, PhD, studied at the University of Debrecen in Debrecen, Hungary, followed by internal medicine residency training at Cornell University. Before his fellowship in cardiovascular medicine, Feher joined the Yale Translational Research Imaging Center (Y-TRIC) to study multimodality imaging techniques used for the investigation of the coronary microcirculation.
Feher is the recipient of American Physiological Society Cardiovascular Section Research Recognition Award, the Japanese Society for Microcirculation Young Investigator Award, and the Hal O’Brien Rising Star Award for his research on coronary microcirculation. He was also selected for the American College of Cardiology (ACC) Young Author Achievement Award for the study “Computed Tomographic Angiography Assessment of Epicardial Coronary Vasoreactivity for Early Detection of Doxorubicin-Induced Cardiotoxicity,” which was published in the journal JACC: CardioOncology.
Jennifer M. Kwan MD, PhD
Jennifer M. Kwan MD, PhD, graduated from the University of Illinois College of Medicine Medical Scientist Training Program in 2013. She completed her residency and postdoctoral training at the University of Illinois Chicago followed by postdoctoral work as a visiting scholar at the University of California, San Francisco to study cardiotoxicities associated with oncologic therapies.
As a physician-scientist, Kwan chose Yale’s cardiovascular medicine and cardio-oncology fellowship programs to pursue her interests. She worked with Lauren A. Baldassarre, MD, on a project to evaluate the cardiovascular outcomes of patients on the immunotherapy agent, mogumulizumab, after reporting the first case of mogamulizumab related myocarditis, and has evaluated cardiovascular toxicities associated with tyrosine kinase inhibitors and immune checkpoint inhibitors, which was presented at the American College of Cardiology 2022 Scientific Session. Kwan also spearheaded a project to evaluate the impact of clonal hematopoiesis of indeterminate potential (CHIP). As a faculty member, she will join the Yale Cardiovascular Research Center (YCVRC) and aims to establish a CHIP clinic in conjunction with hematology to provide clinical, preventative care and identify novel therapeutics for this cohort. Kwan was also recently awarded a KL2 from the Yale Center for Clinical Investigation (YCCI) and will be a YCCI Junior Faculty Scholar. In addition to assessing mechanistic studies on how CHIP promotes cardiovascular disease, she is investigating CHIP and novel somatic variants and their effects on cardiovascular health and outcomes using large patient cohorts.
Katherine Clark, MD, MBA
Katherine Clark, MD, MBA, received her medical degree from the Perelman School of Medicine at the University of Pennsylvania where she distinguished herself as an outstanding medical resident. In 2015, she earned an MBA in Health Care Management from the Wharton School of Business. After completing her fellowship training, Clark served as an advanced heart failure and transplant fellow.
Clark is an active member of the Women in Cardiology Connecticut Chapter of the ACC, the national ACC Women in Cardiology Communications Work Group, and the Take her Health to Heart Coalition. Her research interests focus on innovation in the care of heart failure patients through evaluating both therapeutics, as well as technologies with advanced imaging techniques. She co-authored an editorial in JAMA with Eric J. Velazquez, MD, on the need to reduce heart failure hospitalizations.
Samuel W. Reinhardt, MD
Samuel W. Reinhardt MD, completed his undergraduate work at Yale University, where he was elected to Phi Beta Kappa, and completed medical school at Washington University in St. Louis School of Medicine, where he was elected to Alpha Omega Alpha. He stayed on at Washington University/Barnes-Jewish Hospital for his residency training in internal medicine, where he was the 2015 recipient of the Tom Steinberg Award for excellence in research. His career interests include cardiovascular imaging, advanced heart failure, underserved populations, global cardiovascular health, and developing strategies to improve quality of life for patients through outcomes research. He serves as a reviewer with the Journal of Cardiac Failure and the American Heart Journal.
The Section of Cardiovascular Medicine offers training programs in general cardiovascular medicine, as well as subspecialty training in adult congenital heart disease, advanced heart failure and transplantation, cardiac imaging, electrophysiology, interventional cardiology, cardio-oncology, and research fellowships. To learn more about educational opportunities in cardiovascular medicine, visit our website.